PubMed Health⌕ Search

PubMed · 15751912

Bariatric surgery.

Abstract

The surgical treatment of obesity is indicated in patients who have failed sincere attempts at medical therapies to lose weight. The BMI must exceed 40 or exceed 35 and be associated with at least two comorbid conditions. Comorbid conditions include diabetes mellitus, hypertension, obstructive sleep apnea, hyperlipidemia, and other weight related conditions that may benefit from weight loss. Patients need to be educated concerning the specific operation to be performed. They must be taught what they need to do to optimize the likelihood of success of the surgery, and they must have an understanding concerning the potential adverse side effects. When this format is followed, bariatric surgery is a legitimate treatment for morbid obesity, and the only treatment that is generally successful.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

William J Raum, Louis F Martin. 2005. Bariatric surgery.. https://pubmed.ncbi.nlm.nih.gov/15751912/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Obesity: a problem of darwinian proportions?

Obesity has been described as an abnormality arising from the evolution of man, who becomes fat during the time of perpetual plenty. From the perspective of "Darwinian Medicine," if famine is avoided, obesity will prevail. Problems regarding obesity arise within many disciplines, including socioeconomic environments, the educational system, science, law, and government. This article will discuss various ethical aspects of several disciplines regarding obesity, with a focus on scientific inquiry. We will discuss this within the categories: (1) chronic kidney disease predialysis, (2) dialysis, and (3) renal transplantation. This article aims to help nephrologists and their patients navigate through the ethical aspects of obesity and chronic kidney disease.

Bariatrics↗

Intragastric balloons: a temporary treatment for obesity.

(1) Intragastric balloons are a temporary non-surgical obesity treatment that induces short-term weight loss by partially filling the stomach to achieve satiety and reduce food intake. (2) Moderate weight loss may be achieved if patients adhere to a weight-reduction program. Weight gain often recurs when the balloon is removed after six months. (3) Abdominal pain, nausea, and vomiting are common, particularly in the first week after balloon implantation. (4) More data on benefits, harm, and cost effectiveness are required before the intragastric balloon can be compared with other short-term weight loss interventions, including low-calorie diets.

Bariatrics↗